by investoropportunity | Mar 15, 2023 | Company Research, Health, Home Page Feature Articles, Technology, Uncategorized
PharmAla is the first for-profit company to synthesize clinical-grade (GMP) MDMA and make it available for sale to both researchers and qualified patients. PharmAla will increasingly develop a target on its back for acquisition and we expect a rise in marketcap via...
by investoropportunity | Jan 21, 2023 | Health, Home Page Articles of Insight, Technology
Editas Medicine currently trades at an enterprise value of just $561 million, but its IP portfolio alone is worth billions. This stock traded at over $80/share 2 years ago and is now under $9/share, however the reasons for buying then are just as strong now. It’s...
by investoropportunity | Nov 18, 2022 | Company Research, Health, Home Page Articles of Insight, Technology
Vicarious Surgical Robotic System was added to Time Magazine’s list for the ‘Best Inventions of 2022’ — for reference; Apple’s iPhone was featured by Time in 2007 Best Inventions — NYSE: RBOT has moon-shot potential. Vicarious Surgical...
by investoropportunity | Jul 28, 2022 | Health, Home Page Articles of Insight
Age-related memory loss can be reversed, scientists make breakthrough in mice by Alfred Newman Bottom Line/Synopsis: “Scientists at Cambridge & Leeds have successfully reversed age-related memory loss in mice and say their discovery could lead to the development...
Recent Comments